Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parp Inhibitors and Radiotherapy: A New Combination for Prostate Cancer (Systematic Review)
I. Rivero Belenchón, Carmen Belen Congregado Ruiz, Carmen Sáez, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12978-12978
Open Access | Times Cited: 10

Showing 10 citing articles:

Poly(ADP-Ribose) Polymerase (PARP) Inhibitors for Cancer Therapy: Advances, Challenges, and Future Directions
Denys Bondar, Yevgen Karpichev
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1269-1269
Open Access | Times Cited: 7
Method for determining a Prostate Cancer LET Sensitivity Index (PCLSI) using tumour-specific DDR mutations for proton RBE
Mark Artz, Michael Vieceli, Jiyeon Park, et al.
Journal of Radiotherapy in Practice (2025) Vol. 24
Closed Access
The biological essence of synthetic lethality: Bringing new opportunities for cancer therapy
Meiyi Ge, Jian Luo, Yi Wu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 4
Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer
Yijun Xie, Di Xiao, Duo Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
A review of gut failure as a cause and consequence of critical illness
Danielle E. Soranno, Craig M. Coopersmith, Jessica F. Brinkworth, et al.
Critical Care (2025) Vol. 29, Iss. 1
Open Access
Emerging strategies to overcome PARP inhibitors' resistance in ovarian cancer
Rui Bi, Li Chen, Mei Huang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189221-189221
Open Access | Times Cited: 2
Unravelling the molecular basis of PARP inhibitor resistance in prostate cancer with homologous recombination repair deficiency
Nabila Zaman, Atar Singh Kushwah, Anagha Badriprasad, et al.
International review of cell and molecular biology (2024), pp. 257-301
Closed Access
Targets for improving prostate tumor response to radiotherapy
Fengguang Li, Yizhi Yu, Ming Jiang, et al.
European Journal of Pharmacology (2024), pp. 177149-177149
Closed Access
Polyphenols mitigating inflammatory mechanisms in inflammatory bowel disease (IBD): focus on the NF-ƙB and JAK/STAT pathways
Elysha Nur Ismail, Reezal Ishak, Sharmili Vidyadaran, et al.
Inflammopharmacology (2024)
Open Access
Olaparib bei biochemischem Rezidiv des High-risk-Prostatakarzinoms nach Prostatektomie
Katharina Hintelmann, Lukas Clemens Böckelmann
Strahlentherapie und Onkologie (2024)
Open Access
Page 1

Scroll to top